Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Gross Profit (2019 - 2025)

Outset Medical (OM) has disclosed Gross Profit for 7 consecutive years, with $12.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit rose 13.81% to $12.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $46.8 million, a 21.24% increase, with the full-year FY2025 number at $46.8 million, up 21.24% from a year prior.
  • Gross Profit was $12.2 million for Q4 2025 at Outset Medical, up from $11.6 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $12.2 million in Q4 2025 to a low of $289000.0 in Q1 2021.
  • A 5-year average of $7.0 million and a median of $7.4 million in 2023 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: skyrocketed 1437.02% in 2022, then grew 13.81% in 2025.
  • Outset Medical's Gross Profit stood at $3.3 million in 2021, then soared by 58.78% to $5.3 million in 2022, then soared by 46.25% to $7.7 million in 2023, then surged by 39.35% to $10.7 million in 2024, then increased by 13.81% to $12.2 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Gross Profit are $12.2 million (Q4 2025), $11.6 million (Q3 2025), and $11.9 million (Q2 2025).